Background. Two concurrent, childhood leukemia clusters have been identified in the southwestern United States at Fallon, Nevada, and Sierra Vista, Arizona. Additionally, Fallon, Nevada has also experienced concurrent contamination by atmospheric tungsten particles. The etiology of leukemia is not known. Hypothesized risk factors for leukemia are environmental exposure, genetic predisposition, and viral infection. Additionally, strong evidence supports a prenatal origin. Our objective is to generate testable hypotheses towards elucidating the probable, multi-factorial etiology of leukemia by identifying the exposures unique to Fallon, Nevada, and held in common with Sierra Vista, Arizona, then exposing C57BL/6 mice, while in utero, to these chemicals to ascertain their leukemogenic potential. Utilizing advances in medical geology to analyze tree rings, surface dust, lichens and atmospheric particulate matter, we have identified tungsten and arsenic as potentially relevant to leukemogenesis. Methods. We utilized microarray (Affymetrix 430A 2.0 mouse) and real-time RT-PCR of Dmbt1 transcriptome-expression in spleen tissue collected from four-week-old C57BL/6 mouse pups (N = 6-8/group/gender) exposed, while in utero, to tungstate, arsenite, tungstate/arsenite and longitudinal controls at 20% of the normalized exposure a human mother would receive during gestation at mean environmental concentrations. Results. Prenatal exposure to tungstate is associated with a 37 + 1.2-fold (p = 0.012) decrease in DMBT1 transcriptome-expression in mice expressing DMBT1 at high levels. Additionally, prenatal exposure to tungstate/arsenite significantly altered a cytokine-cytokine receptor interaction pathway associated with lymphocyte activation and a network associated with hematological/immunological disease. Conclusion. Because DMBT1 protein products are known to aggregate viruses and possibly regulate immune response, additional research is warranted to determine the potential that prenatal exposure to tungstate or tungstate/ arsenite has to increase susceptibility to viruses and to induce leukemogenesis.
INTRODUCTION
Fallon, Nevada has concurrently experienced a uniquely significant childhood leukemia cluster (Steinmaus et al. 2004) and atmospheric contamination by tungsten particles (Table 1) . Because the etiology of leukemia is not known, this suggested positive correlation between temporal elevations in tungsten levels, and the incidence of childhood leukemia strongly warrants renewed scrutiny of the effect of tungsten on Tungsten compounds have been reported to be toxicologically and biologically inert in Escherichia coli, except for effects on clpB and osmY stress promotergenes and inhibition of enzymes with nucleic-acid substrates (Tajima 2003) . Additionally, tungsten has been reported to cross the placenta in murines (Wide et al. 1986) ; to compromise fetal ossification (Nadeenko et al. 1978) ; and to be preferentially retained in bone tissue (Wase 1955; Mullen et al. 1976; Ando et al. 1989) . Leukemogenic risk factors are hypothesized to be environmental exposure; genetic predisposition (primarily the prenatal formation of chimeral genes resulting from chromosomal translocations); and viral infection with a probable multi-factorial etiology (reviewed in Belson et al. 2007; Rubin et al. 2007) . We are profiling and comparing the environmental exposures in two concurrent, childhood leukemia clusters in the Southwestern United States at Fallon, Nevada (CDC 2003; CDC 2006; Rubin et al. 2007; Steinberg et al. 2007 ) and Sierra Vista, Arizona (Humble and Flood 2002; CDC 2006) . Utilizing prenatal exposures in a whole system (C57BL/6 mice), we are modeling those exposures shared in common by the leukemia clusters. We hypothesize that prenatal exposure to an environmental chemical, held in common by communities experiencing elevated rates of leukemia, but not experienced by geographically similar control communities, results in genetic changes associated with increased susceptibility towards virus-induced leukemogenesis.
We present a summary of our environmental profiling of the metal exposures unique to Fallon, Nevada (Table 1 ). The unique portion of the atmospheric, metallic particulate matter is significantly elevated concentrations of cobalt and tungsten, which co-vary as a function of time. While the residents are exposed to elevated concentrations of arsenic, this alone is not unique to Fallon, as compared to geographically similar communities. The temporal time study, utilizing dendrochemistry of tree rings, indicates that not only are tungsten concentrations elevated as compared to control communities, medians of 96 ppb vs. 39 ppb respectively (p = 0.04), but that tungsten concentrations were about the same as the control communities, 39 ppb, a decade prior to the onset of the childhood leukemia cluster. The concentration of cobalt in Fallon has been consistently elevated over the past 15 years as compared to the control communities. The combinations of elevated concentrations of tungsten with arsenic as well as tungsten with cobalt may be relevant to leukemogenesis. Along with elevated concentrations of atmospheric tungsten, preliminary results in Sierra Vista indicate that atmospheric arsenic is also periodically elevated (data not shown); therefore, we chose to use tungsten, arsenic, and tungsten/arsenic in a combinative study. Arsenic is a known carcinogen, but is not known to be a leukemogen. 
Mouse exposure study, Part II
C57BL/6 eight-week-old female mice, purchased through an IACUC-approved protocol, were tagged with an identification chip and randomly assigned to an exposure group to receive sodium tungstate (Na 2 O 4 W⋅2H 2 O, Acros Organics), sodium arsenite (AsNaO 2 , Acros Organics), both agents, or neither through aerosol and water at 20% of the environmental concentrations and normalized from the quantity that a pregnant woman would inhale/ingest during a 40-week gestation in Fallon, Nevada. Exposure concentrations for tungstate were 187.517 g/L as an aerosol delivered as described above, and 0.1403 mg/L in water consumed ad libitum. Exposure concentrations for arsenite were 0.604 g/L as an aerosol and 0.00875 mg/L in water. All groups were housed in sterile, micro-isolation rooms. The female mice were exposed on a daily basis for one week, mated over the weekend with C57BL/6 male mice of equivalent age, and then exposures were continued until parturition. After weaning, the pups were sorted by gender, and their immune organs (bone marrow, spleen, thymus and liver) were harvested and preserved in RNALater (Ambion).
Transcriptome studies
Total RNA was extracted from W/As and control spleen tissue, utilizing a commercially available kit (BioRad). Because the average child does not develop leukemia, and because we did not want to average out the differential expression of constituent genes involved in a potential translocation should a small population of pre-leukemic clones be present, we did not pool the samples. Affymetrix 430A 2.0 mousegene chip arrays were hybridized and read with an Agilent/Affymetrix 2500A scanner. Raw data (.CEL files) were analyzed with GeneSpring v7.0 software containing the GC-RMA algorithm (Wu et al. 2004) . Transcript signals were loaded into BRB ArrayTools (http:// linus.nci.nih.gov/BRB-arraytools.html) and filtered based on the variance of each transcript. The log ratios of the variance were compared to the median of all transcript variances and significant (p = 0.001) transcripts selected. Onto-Express (http://www.geneontology.org/GO.tools.microarray.shtml) was utilized for ontology and BioRag for pathway analyses from which DMBT1 was selected for further RT-PCR studies. Network evaluation was conducted with Ingenuity Pathways Analysis (IPA) software (Ingenuity Systems, Mountain View, CA, USA), in which mapping to a network was scored (-log 10 (p-value)) and ranked. The RT-PCR data were generated utilizing a DMBT1 assay (Applied Biosystems, ABI) and ABI 7000 and 7300 SDS equipment utilizing GAPDH for determining baseline expression and evaluated with the Delta Delta-Cycle Threshold method.
STATISTICAL ANALYSES
Statistical analyses were conducted with Excel's XLStat 2007 and the data presented as mean + standard error of the mean (SEM). Significance was determined with a Kruskal-Wallis test and a two-tailed Student ttest adjusted for multiple comparisons with significance accepted when p < 0.05.
RESULTS

Hematological profile
Leukemia affects the production of blood cells, resulting in an altered hematological profile such as anemia, thrombocytopenia, neutropenia and, primarily, leukocytosis comprising immature cells called blasts. We exposed young adult, male and female mice (N = 10/ group), to ammonium paratungstate through aerosol and/or water. No blasts were observed in the peripheral blood samples, suggesting that exposure to tungstenalone is not a direct leukemogen in the young adult. However, tungsten exposure through water, aerosol, and both exposure routes altered blood parameters (primarily increasing the incidence of thrombocytopenia in both genders and dual symptoms of anemia/thrombocytopenia in males) during the first 84 days of exposure, which resolved as the mice grew older (data not shown).
TRANSCRIPTOME CHANGES
In utero exposure to tungstate/arsenite altered the expression of 177 genes (154 mapped and 22 unmapped) greater than 10-fold. Approximately 20 of these genes may be significant above what is expected due to chance. Analysis of ontology demonstrated that the majority of the differentially expressed genes were associated with hydrolase activity (elastases, kallikreins and trypsins), with the majority of these genes being down-regulated 100-fold, with the exception of cathepsin M which was up-regulated 12.6-fold. The biological processes most significantly represented in this pool of genes were cellular, including cell differentiation and proliferation (DMBT1, Phospholipase and Fibroblast Growth Factor) and cytoskeletal organization (MyosinVb, Piccolo, Filaggrin, and Expressed Sequence AV006891). Pathway analysis of these 177 genes with differential expression greater than 10-fold yielded 15 pathways which included Mek/Erk/Wnt pathways, antigen presentation and processing pathways, and cytokine interactions involving lymphocytic signaling (Table 2 ). Of these differentially expressed genes, we are particularly interested in the gene named Deleted in Malignant Brain Tumors 1 (DMBT1): anti- We verified the gene microarray expression of DMBT1, and then conducted a real-time RT-PCR investigation of DMBT1 expression in male and female C57BL/6 pups (N = 6-8/group/gender) exposed while in utero to tungstate, arsenite, tungstate/arsenite and longitudinal controls through aerosol and water. The amplification plots of DMBT1 expression demonstrated that DMBT1 is not constitutively expressed in spleen tissue. Four pups from each group demonstrated no expression of DMBT1, except for the arsenic group, which demonstrated expression in every sample tested. Prenatal exposure to arsenic demonstrated a strong bimodal distribution, and most other exposure groups (longitudinal controls and tungstate/arsenite, but not tungstate-alone) demonstrated a similar tendency. Some spleen samples expressed DMBT1 at high levels (the amplification plots formed a sigmoid curve) and some samples expressed at low levels (only the linear portion formed). When ranked by expression level, the low-expressing samples demonstrated no difference in expression level between groups, but the high-expressing samples demonstrated a significant difference according to type of in utero exposure (Figure 1) . A Kruskal-Wallis test did not find a significant difference between the exposed pups and the controls, as whole populations. However, the differences observed in the high expressers, hypothesized to occur because of individual alleles (Blackburn et al. 2007; Mollenhauer et al. 2002a) or G0/G1 arrest and cell growth reduction (Kang et al. 2005) , was significant for prenatal exposure to tungsten (Figure 2 ).
Networks containing DMBT1 were focused on the gene Cytochrome P450, family 3, subfamily A, polypeptide 4 (CYP3A4), which codes for an enzyme involved in metal ion binding (Table 3 ) and centered on the down-regulation of the transcription factor E2F1 (Table 4 ). Additionally, Ubinuclein 1, which competes with an Epstein-Barr virus (EBV) early gene for AP-1 binding sites (Aho et al. 2000) , was down-regulated. A network associated with immunological/hematological disease (Table 4) indicates impaired immune defense against dsRNA, virus E3 proteins, Hepatitis C Virus and repair of DNA lesions in hematopoietic tissues.
DISCUSSION
We hypothesize that prenatal exposure to an environmental chemical, held in common by communities experiencing elevated rates of leukemia, but not experienced by geographically similar control communities, results in genetic changes associated with increased susceptibility towards virus-induced leukemogenesis. We have demonstrated with multiple measures that Fallon is contaminated with ambient particles of tungsten. We have demonstrated that tungsten, alone, does not induce leukemia in the adult mouse, but we have Sample Number Delta Threshold Cycle Control W As W/As Figure 1 . Expression of DMBT1 ranked by delta-threshold-cycle depicting populations of C57BL/6 mouse pups expressing DMBT1 at high and low levels. Statistical analysis of the ∆∆Ct for the entire group as a whole demonstrated no significant difference (p = 0.058) from the controls; however, the difference between As and W/As was significant. a. Genes colored red were up-regulated and genes colored green were down-regulated in the gene microarray analysis. Genes in black capitals were differentially expressed less than 10-fold. a. Genes colored red were up-regulated and genes colored green were down-regulated in the gene microarray analysis. Genes in black capitals were differentially expressed less than five-fold.
also verified reports that tungsten ores may alter blood parameters (Idiiatullina 1981; Misiewicz 1983) , and have discovered that this hematopoietic influence is greatest while the mice are young. We demonstrated that in utero exposure to tungstate is associated with significantly reduced transcription of the gene, Deleted in Malignant Brain Tumors 1 (DMBT1), whose protein products aggregate bacteria and viruses, by 37 + 1.2-fold (p = 0.012) in mice that express DMBT1 at high levels, the implications of which are discussed below. We have suggested that this tungstate-induced downregulation of DMBT1 may be mediated by Cytochrome P450, family 3, subfamily A, polypeptide 4 (CYP3A4) and the transcription factor E2F1. Additionally, we found that in utero exposure to tungstate/arsenite generated differential expression for seven of the 13 genes identified as being consistently altered in acute lymphoblastic leukemias (Mullighan et al. 2007) , one of which is ATM and is involved in a significantly altered pathway.
Expression of DMBT1
The DMBT1 gene was first identified by its homozygous deletion in glioblastoma multiforme (Rasheed et al. 1995; Albarosa et al. 1996) , and as a candidate tumor suppressor by its presence in a locus (10q25.3-q26.1) identified by loss of heterozygosity in malignant brain tumors (Mollenhauer et al. 1997) , and subsequently in other forms of cancer in epithelial tissues such as breast, colorectal, esophageal/gastric, pancreatic, and lung cancers (Mori et al. 1999; Takeshita et al. 1999; Wu et al. 1999; Hustinx et al. 2004; Robbe et al. 2005; Blackburn et al. 2007 ). However, some investigations have demonstrated elevated expression of DMBT1 in slow-growing, differentiated tumors (Kang et al. 2005) . We discovered variable levels of DMBT1 expression in spleen tissue from C57BL/6 four-weekold pups in all exposure groups and in both genders. Variable levels of DMBT1 expression have been attributed to individual alleles (Mollenhauer et al. 2002a; Blackburn et al. 2007) , antigenic stimulus (Bikker et al. 2004; Hartshorn et al. 2006) or G0/G1 arrest and cell growth reduction during differentiation (Kang et al. 2005) .
Several groups (Takeshita et al. 1999; Wu et al. 1999; Petersen et al. 2000; Mollenhauer et al. 2002b) , investigating the association of DMBT1 alleles and lack of expression in tumors, concluded that mutations in DMBT1 occur at low frequency in cancer. If allelic differences are associated with variable DMBT1 expression, it is most likely within the promoter region, but largely remains uninvestigated. We believe microbial stimulus is not the cause of the dynamic expression of DMBT1 within the controls, because we housed our mice in sterile, micro-isolation rooms. The most likely explanation for the variable levels of DMBT1 expression is provided by a study in a gastric cell line, which demonstrates that extracellular signal-related kinase (ERK) and protein kinase C (PKC) mediated the downregulation of DMBT1 expression and the initiation of cell differentiation. Additionally, inhibition of proliferation, either with an ERK inhibitor or high-density seeding, was associated with marked increase in DMBT1 expression (Kang et al. 2005) . 
Tungstate-associated suppression of DMBT1
The differentiation hypothesis predicts that the tungstate-associated suppression of DMBT1 (Figure 2 ) in cells which may be receiving signals to differentiate, may encourage epithelial cells to ignore signals to exit the cell cycle, but instead encourages them to continue to proliferate. Exposure to tungstate may encourage tumorigenesis of epithelial tissues as previous research has suggested (Wei et al. 1985) .
Additionally, if prenatal exposure to tungstate, which decreases the high-level expression of DMBT1 (Figure 2) , also results in decreased levels of protein product available to aggregate microorganisms, such as the human herpes virus-4 (EBV) (which target B-cells for proliferation), more may escape aggregation to infect B lymphocytes. As the total number of EBVinfected cells increases, the probability increases that one of the cells targeted for proliferation by EBV may be a preleukemic B-cell harboring a translocation generated spontaneously during in utero growth and which has managed to escape apoptosis through down-regulation of ATM (Table 2) .
Although the dams were exposed to Na 2 WO 4 dissolved into physiological saline, and brought to neutral pH or dissolved into drinking water, the actual tungsten molecule formed under physiological conditions which may be associated with the down-regulation of DMBT1 transcription, is not known. Under some physiological conditions (i.e. neutral pH), the tungstate anion may polymerize with itself, forming polyoxotungstates (POTs) around a phosphate or other metal cation, such as molybdenum or cobalt. Arsenite-POTs have also been synthesized. POTs demonstrate various physiological effects, dependent upon the nature of the central atom, and most likely as a consequence of the high anionic valency of the molecule (e.g. (PW 11 O 39 ) 7-at neutral pH), coupled with a relatively small molecular radius. These physiological effects associated with phosphorous-POTs include inhibition of factors IIa and Xa in the presence of anti-thrombin III and inhibition of anion-transport in erythrocytes and porcine sperm. The WO 4 2-ion did not exhibit these traits (reviewed in Tajima 2005).
Suggested mechanism of tungstateassociated suppression of DMBT1
The cancer networks (Table 3) primarily involve cellto-cell interactions and signal transduction. Networks containing DMBT1 suggest that tungstate-induced down-regulation of DMBT1 may be mediated by the gene CYP3A4 (Table 3) , which codes for an enzyme involved in metal-ion binding, and the down-regulation of the transcription factor E2F1 (Table 4) . While CYP3A4 is not reported to bind tungsten, it is consistent with the wide range of xenobiotics that CYP3A4 is able to process. Both the ten-fold network (Table 3) and five-fold network (Table 4 ) connect DMBT1 through the 1.6-fold up-regulation of Map3K14 (Chen et al. 2003) .
MAP3K14 has been shown to be regulated by the E2F1 transcription factor (Stanelle et al. 2002) , which was down-regulated 1.5-fold and which regulates cell cycle progression through the G1/S phase transition (La Thangue 1994) . Mice deficient in E2F1 demonstrate a more rapid and increased entry into the S phase upon antigenic stimulus (Salam et al. 2004) . Such biological consequences may also include reduced DMBT1 expression, whose increased expression is associated with exit from the cell cycle (Kang et al. 2005) . This network also suggests other down-stream consequences which may be mediated by transcription factor CEBPA (CCAAT/enhancer binding protein alpha), and which interacts with UBN1 (Ubinuclein 1), both of which were down-regulated (Table 4) . UBN1 competes with EB1, an EBV early gene, for AP-1 binding sites in the reactivation of latent EBV infection (Aho et al. 2000) . Although antimony-and siliconPOTs have potent antiviral activity, this may be only for concurrent exposures. While dual treatment of a Burkitt's lymphoma-derived cell line with antimony-POT and an EBV-reactivation agent (5-iodo-2'-deoxyuridine, IUdR) decreased the expression of the EBV early antigen as compared to IUdR controls, pretreatment with antimony-POT 24-hours prior to reactivation, enhanced the expression of the EBV early antigen (Souyri-Caporale et al. 1984) . The cancer network with DMBT1 (Table 4) suggests that a prenatal exposure to tungstate may down-regulate Ubinuclein 1, possibly potentiating the enhanced expression of the EBV early antigen.
CONCLUSION
We have reported that prenatal exposure to tungstate is associated with a decrease in transcriptional expression of DMBT1 by 37 + 1.2-fold (p = 0.012) in mice expressing DMBT1 at high levels. This association alone does not indicate that prenatal exposure to tungstate is leukemogenic or carcinogenic. However, it does indicate, along with the possible alterations in the ATM pathway and network connections associated with EBV interactions, and possibly HCV and HV-3, that further research is warranted to ascertain the leukemogenic ability of tungstate/arsenite exposures.
